Scarica l'app Stockscreener
1.01
2.65%
0.0261
Pre-mercato:
1.02
0.01
+0.99%
Fractyl Health Inc Borsa (GUTS) Ultime notizie
Fractyl Health Reports Q2 2025 Financial Results and Progress - MSN
What’s the profit margin of Fractyl Health Inc.July 2025 Big Picture & AI Forecasted Entry and Exit Points - thegnnews.com
Fractyl Health outlines upcoming REMAIN-1 and Rejuva milestones while strengthening cash position - MSN
Fractyl Health (GUTS) and the Post-GLP-1 Weight Maintenance Opportunity: A Clinical and Commercial Breakthrough in Metabolic Disease - AInvest
Fractyl Health's Strategic Positioning in the Post-GLP-1 Market: A Catalyst-Driven Opportunity for 2025–2026 - AInvest
Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Earnings call transcript: Fractyl Health Q2 2025 sees increased R&D, net loss - Investing.com Australia
Short Interest Drops in Fractyl Health Inc. After RallyBreakout Confirmation With Entry Tracker Enabled - beatles.ru
Bollinger Bands Expand on Fractyl Health Inc. — Volatility AheadShort Term Setup With Predictive Chart Confirmed - beatles.ru
Biotech Alert: Searches spiking for these stocks today - TipRanks
Fractyl Health shares rise 1.75% intraday after closing $23 million public offering. - AInvest
Fractyl Health announces proposed public offering - MSN
Fractyl Health raises $23 million in public offering with warrants By Investing.com - Investing.com Canada
Fractyl Health raises $23 million in public offering with warrants - Investing.com India
Fractyl Health Announces Closing of $23 Million - GlobeNewswire
Fractyl Health Raises $23M in Public Offering, Could Expand to $69M Through Warrants - Stock Titan
Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference - The Manila Times
Fractyl Health to Report Second Quarter 2025 Financial - GlobeNewswire
Fractyl Health prices 19.05M shares at $1.05 in underwritten public offering - TipRanks
Fractyl Health's GUTS Plummets 47%: What's Fueling the Sudden Freefall? - AInvest
Fractyl Health stock plunges after $20 million public offering - Investing.com India
Fractyl Health stock plunges after $20 million public offering By Investing.com - Investing.com Australia
Fractyl Health (GUTS.O) Plummets 49%: Technical Signals, Order-Flow Clues, and Sector Divergence Point to Key Catalyst - AInvest
US Stocks Edge Higher; McDonald's Posts Upbeat Earnings - Benzinga
Fractyl Health prices $20 million public offering of common stock - Investing.com
Fractyl Health prices $20 million public offering of common stock By Investing.com - Investing.com Canada
Fractyl Health announces pricing of $20 million underwritten public offering - MarketScreener
Fractyl Health Announces Pricing of $20 Million Underwritten Public Offering - GlobeNewswire
Fractyl Health Secures $20M Funding to Advance Revolutionary Diabetes and Obesity Therapeutics - Stock Titan
Fractyl Health Stock Plunges 27.81% on Public Offering - AInvest
Fractyl Health plunges after launching stock offering - TradingView
Fractyl Health Drops 26% Pre-Market: What You Need to Know - Benzinga
Fractyl Health Earnings Preview: Metabolic Disease Innovator Updates Investors on August 12 - Stock Titan
Fractyl Health announces two-year follow-up data from Revita study - TipRanks
Fractyl Health announces common stock offering, no amount given - TipRanks
Fractyl Health announces proposed public offering of common stock By Investing.com - Investing.com Nigeria
Fractyl Health Reports Potent and Durable Two-Year Real-World Outcomes with Revita® Showing Sustained Weight Loss and Improved Glucose Control After a Single Procedure - The Manila Times
Fractyl Health announces proposed public offering of common stock - Investing.com
Fractyl Health Announces Proposed Public Offering - GlobeNewswire
Metabolic Disease Pioneer Fractyl Health Launches Major Public Offering with Innovative Warrant Structure - Stock Titan
Fractyl’s Revita procedure shows durable weight loss in diabetes patients - Investing.com
Fractyl Health Reports Potent and Durable Two-Year - GlobeNewswire
Breakthrough Diabetes Device Maintains 9.6% Weight Loss for 2 Years with Single TreatmentNew Real-World Data - Stock Titan
Can machine learning forecast Fractyl Health Inc. recoveryLow Risk Trade Timing with Analysis Metrics - Newser
Using economic indicators to assess Fractyl Health Inc. potentialFree Real-Time Analysis With Entry Targets - Newser
How Fractyl Health Inc. stock performs during market volatilityRisk/Reward Optimization Entry Point Analysis - Newser
Predicting Fractyl Health Inc. trend using moving averagesShort-Term Bounce Forecast for Oversold Stocks - Newser
Canaccord Genuity Reiterates Buy Rating on Fractyl Health (GUTS) - MSN
Published on: 2025-08-03 21:36:23 - Newser
Advanced analytics toolkit walkthrough for Fractyl Health Inc.Weekly Movement Forecast With Chart Signals - Newser
Is Fractyl Health Inc. stock overvalued or undervaluedBuild a portfolio that withstands market volatility - Jammu Links News
When is Fractyl Health Inc. stock expected to show significant growthBreakthrough stock performance - Jammu Links News
What are the latest earnings results for Fractyl Health Inc.Discover stocks with superior performance - Jammu Links News
What drives Fractyl Health Inc. stock priceCapital growth strategies that work - Jammu Links News
What earnings revisions data tells us about Fractyl Health Inc.Technical Reversal Pattern Summary and Tracker - Newser
What are analysts’ price targets for Fractyl Health Inc. in the next 12 monthsStay ahead with advanced stock screening tools - Jammu Links News
Why Fractyl Health Inc. stock attracts strong analyst attentionMulti-Bagger Potential Stock Forecast Tools Released - beatles.ru
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):